Table 3.

Multivariable analysis for the whole group

	Hazard ratio (95% CI)	P
OS
Transplant in 2012-2014	0.90 (0.57-1.42)	.65
Age, per year	1.00 (0.99-1.02)	.49
RAEB-1 or –2	1.54 (0.82-2.89)	.18
Transformation to AML	2.00 (1.07-3.74)	.031
Non-CR at transplant	1.88 (1.24-2.86)	.003
Bone marrow vs peripheral blood*	0.90 (0.56-1.47)	.68
Female donor to male recipient	1.61 (1.06-2.44)	.026
CMV-positive recipient	1.53 (0.95-2.46)	.078
≥2 HLA loci mismatch	1.22 (0.69-2.16)	.49
MAC	1.65 (1.05-2.60)	.032
TBI	1.20 (0.75-1.92)	.44
In vivo TCD	0.96 (0.48-1.92)	.91
Ex vivo TCD	0.74 (0.32-1.71)	.48
PT-CY	0.45 (0.20-1.01)	.054
PFS
Transplant in 2012-2014	0.92 (0.59-1.42)	.70
Age, per year	1.01 (0.99-1.02)	.40
RAEB-1 or −2	1.35 (0.76-2.40)	.31
Transformation to AML	1.74 (0.98-3.09)	.060
Non-CR at transplant	1.91 (1.28-2.84)	.001
Bone marrow vs peripheral blood*	1.12 (0.72-1.72)	.62
Female donor to male recipient	1.50 (1.00-2.24)	.049
CMV=positive recipient	1.35 (0.87-2.10)	.18
≥2 HLA loci mismatch	1.13 (0.66-1.92)	.66
MAC	1.55 (1.01-2.39)	.045
TBI	1.12 (0.72-1.75)	.61
In vivo TCD	0.89 (0.47-1.69)	.73
Ex vivo TCD	0.75 (0.34-1.66)	.48
PT-CY	0.50 (0.24-1.02)	.056
NRM
Transplant in 2012-2014	0.91 (0.53-1.54)	.72
Age, per year	1.01 (0.99-1.03)	.22
RAEB-1 or −2	1.12 (0.57-2.22)	.74
Transformation to AML	1.62 (0.83-3.17)	.16
Non-CR at transplant	1.88 (1.24-2.86)	.003
Bone marrow vs peripheral blood*	0.90 (0.56-1.47)	.68
Female donor to male recipient	1.61 (1.06-2.44)	.026
CMV-positive recipient	1.53 (0.95-2.46)	.078
≥2 HLA loci mismatch	1.22 (0.69-2.16)	.49
MAC	1.65 (1.05-2.60)	.032
TBI	1.20 (0.75-1.92)	.44
In vivo TCD	0.96 (0.48-1.92)	.91
Ex vivo TCD	0.74 (0.32-1.71)	.48
PT-CY	0.46 (0.21-1.01)	.054

^*Comparison of bone marrow or peripheral blood as the source of stem cells, the reference is peripheral blood.